Clinical trial · Interventional
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
NCT07405931CI-TRIAL-00103162recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a multicenter randomized controlled clinical trial designed to evaluate the clinical efficacy and cost-effectiveness of a digital health platform that integrates a symptom reporting and management software with a standardized telenursing program, allowing cancer patients to actively monitor, report, and self-manage chemotherapy-related adverse effects.
Conditions
Conditions (8)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
| Advanced Colon Cancer | Malignant Colon Neoplasm | CURATED_BROADER | 0.78 |
| Advanced Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
| Advanced Lung Cancer | Malignant Lung Neoplasm | CURATED_BROADER | 0.78 |
| Early Breast Cancer | — | UNRESOLVED | — |
| Early Colon Cancer | — | UNRESOLVED | — |
| Early Gastric Cancer | Early Gastric Carcinoma | ALIAS | 0.90 |
| Early Lung Cancer | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Smart Cancer Care Plus | Other | — | UNRESOLVED |
| Standardized Telenursing | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- NO_INTERVENTION
- label
- Standard Care Group
- description
- Standard care group is the control group, receiving standard care only without using Smart Cancer Care Plus or standardized telenursing.
- type
- EXPERIMENTAL
- label
- ePRO Group
- description
- ePRO group is the experimental group, using Smart Cancer Care Plus without standardized telenursing.
- interventionNames
- Other: Smart Cancer Care Plus
- type
- EXPERIMENTAL
- label
- ePRO + Telenursing Group
- description
- ePRO + Telenursing group is the experimental group, using Smart Cancer Care Plus in combination with standardized telenursing.
- interventionNames
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
Show eligibility criteria text
Inclusion Criteria: * Adults aged 19 years or older * Diagnosed with early or advanced gastric, lung, breast, or colon cancer * Starting first-cycle chemotherapy with a new anticancer agent * Able to use a smartphone without difficulty * Willing to provide informed consent to participate in the study Exclusion Criteria: * Individuals who have difficulty communicating due to cognitive impairment, visual impairment, hearing impairment, or other reasons * Individuals who cannot read, write, or understand Korean * Other individuals deemed inappropriate for participation by the investigators
References
Publications (0)
Data not yet available
No reference posted for this study.